StreetInsider.com News Articles

Form 424B3 Pulsenmore Ltd.

Mon, 13 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260713/26762500.html

Form 424B3 Pulsenmore Ltd.

Mon, 13 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260713/26762500.html

Form 424B3 Pulsenmore Ltd.

Mon, 13 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260713/26762500.html

These Small Caps are Turning Up the Heat

Mon, 13 Jul 2026 10:48:14 -0400

DENVER, July 13, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- From a transformational merger and corporate restructuring at Twin Vee PowerCats, to encouraging Phase 2 clinical data from Q32 Bio, major oncology financing by Agenus, government-backed AI development at Pulsenmore, shareholder returns from LogProstyle, and new third-party testing validating Xeriant's advanced construction materials, this week's developments demonstrate the diverse catalysts capable of reshaping small-cap growth stories.

Twin Vee PowerCats (NASDAQ:VEEE) announced one of the week's most significant corporate restructurings through a definitive agreement that combines a merger with privately held USFM Corporation

These Small Caps are Turning Up the Heat

Mon, 13 Jul 2026 10:48:14 -0400

These Small Caps are Turning Up the Heat

Mon, 13 Jul 2026 10:48:14 -0400

These Small Caps are Turning Up the Heat

Mon, 13 Jul 2026 10:48:14 -0400

Form 6-K Pulsenmore Ltd. For: Jul 13

Mon, 13 Jul 2026 07:38:00 -0400

si-local-file:///var/storage/secattach/20260713/26759866.html

Form 6-K Pulsenmore Ltd. For: Jul 13

Mon, 13 Jul 2026 07:38:00 -0400

si-local-file:///var/storage/secattach/20260713/26759866.html

Form 6-K Pulsenmore Ltd. For: Jul 13

Mon, 13 Jul 2026 07:38:00 -0400

si-local-file:///var/storage/secattach/20260713/26759866.html

Pulsenmore joins Israel AI health sandbox with $1M project

Mon, 13 Jul 2026 07:01:10 -0400

Pulsenmore Ltd. (NASDAQ: PLSM) has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, a joint initiative of the Israel Innovation Authority (IIA) and the Ministry of Health, the company said in a press release. As part of the program, Pulsenmore will receive IIA funding for a $1 million AI development project.

The program provides a regulatory framework for companies to develop, evaluate, and clinically validate AI-based healthcare solutions in collaboration with regulators and the healthcare system.

Pulsenmore's platform allows pregnant women to perform physician-prescribed ultrasound scans at home using the company's device connected to a smartphone. Each scan is

Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project